Accreditation
EACCME®
Language
English
Login
We offer our registered users tailored information, free online courses and exclusive content.
Can't find your password?
Reset it here.
Reset it here.
From poor response to low prognosis concept: The new POSEIDON criteria
From poor response to low prognosis concept: The new POSEIDON criteria
- Reproductive medicine
- Fertility
Friday, Oct 13 - Saturday, Oct 14 2017
Athens, Greece
Registration status
Closed
Target audiences
Clinicians
embryologists
biologists and scientists working in ART.
Files
Introduction
Access learning resources by clicking the Outcomes tab or scroll down to the Scientific Programme.
Overview
Managing patients with impaired or poor ovarian response (POR) is a controversial issue. Number of oocytes retrieved has been adopted as a criterion of POR in most clinical trials, although the threshold number differs considerably between studies. A panel of experts (Patient-Oriented Strategies Encompassing Individualized Oocyte Number, the POSEIDON group) recently proposed new criteria to help guide the physician in handling POR patients. This workshop will introduce the new POSEIDON criteria as a means to improve the management of patients exposed to assisted reproductive technologies, promote more specific approaches to patients with impaired prognosis during IVF, thereby offering better tools with which to optimize IVF success rates.
Learning objectives
By attending this live educational workshop, participants will be able to:
- Grasp the state of art regarding definition of impaired response to ovarian stimulation
- Comprehend the new low prognosis concept and its application in clinical practice
- Individualize and manage women with expected or unexpected prognosis to ART according POSEIDON classification
Accreditation details
Scientific programme
Friday, 13 October 2017
From 09.00 Registration
09.40 Opening
R. Fischer, Germany
09.50 Welcome introduction
C. Alviggi, Italy
Session I - Poor ovarian response: The relationship between quantity and quality
Chair: R. Fischer, Germany
10.00 L1 Why The POSEIDON classification? VIDEO LECTURE
S. Esteves, Brazil
10.25 L2 What is The POSEIDON classification? VIDEO LECTURE
P. Humaidan, Denmark
10.50 Panel discussion
12.00 Lunch
Session II – From predict to treat
Chair: R. Fischer, Germany
13.15 L3 Markers of ovarian reserve: can we use them for daily clinical practice?
A. La Marca, Italy
13.40 L4 The impact of age on oocyte quality VIDEO LECTURE
A. Capalbo, Italy
14.05 L5 The ART Calculator: estimating a new marker of success in ART VIDEO LECTURE
S. Esteves, Brazil
14.30 Panel discussion
16.00 End of the first day
Saturday, 14 October 2017
Session III –Management of The POSEIDON groups
Chair: R. Fanchin, France
08.30 L6 POSEIDON Groups 1 - 2 VIDEO LECTURE
C. Alviggi, Italy
08.55 L7 POSEIDON Groups 3 - 4 VIDEO LECTURE
P. Humaidan, Denmark
09.20 L8 Strategy of accumulation in The POSEIDON groups VIDEO LECTURE
C. Alviggi, Italy
09.45 Panel discussion
10.45 The POSEIDON website
S.C. Esteves (Brazil)
11.00 Coffee break
Session IV – PRACTICAL CASE STUDIES AND DISCUSSION
Chair: R. Fischer, Germany
11.20 Case studies 1-2
C. Alviggi, Italy
12.00 Case studies 3-4
P. Humaidan, Denmark
12.40 General discussion
13.30 Closing remarks
13.40 End of the workshop
Closing lunch
CME provider
EXCEMED - Excellence in medical education
Chair(s)
Carlo Alviggi
Federico II University of Naples
Naples, Italy
Sandro Esteves
ANDROFERT - Andrology & Human Reproduction Clinic
Campinas, Brazil
Robert Fischer
Fertility Centre Hamburg
Hamburg, Germany
Peter Humaidan
Skive Regional Hospital and Faculty of Health
Aarhus University
Fertility Clinic
Skive, Denmark
Speakers
Carlo Alviggi
Federico II University of Naples
Naples, Italy
Peter Humaidan
Skive Regional Hospital and Faculty of Health
Aarhus University
Fertility Clinic
Skive, Denmark
Robert Fischer
Fertility Centre Hamburg
Hamburg, Germany
Sandro Esteves
ANDROFERT - Andrology & Human Reproduction Clinic
Campinas, Brazil
Antonio La Marca
Department of Obstetrics and Gynecology
University of Modena and Reggio Emilia and Clinica Eugin
Modena, Italy
Antonio Capalbo
Biotechnologist Specialist in Medical Genetics, Director of GENETYX Molecular Biology Laboratory
G.EN.E.R.A. Centre for Reproductive Medicine
Rome, Italy
Renato Fanchin
Hospital A. Béclère and University Paris-Sud
Clamart, France
Disclaimer
Reproductive medicine
Publication
Reproductive medicine
Video
Reproductive medicine
Slide kit
Reproductive medicine